47.55
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$46.69
Offen:
$46.21
24-Stunden-Volumen:
58,637
Relative Volume:
0.05
Marktkapitalisierung:
$2.56B
Einnahmen:
$238.11M
Nettoeinkommen (Verlust:
$-31.45M
KGV:
-75.08
EPS:
-0.6334
Netto-Cashflow:
$7.66M
1W Leistung:
-2.26%
1M Leistung:
+1.68%
6M Leistung:
+61.24%
1J Leistung:
+187.52%
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
AXGN
Axogen Inc
|
47.56 | 2.51B | 238.11M | -31.45M | 7.66M | -0.6334 |
|
ABT
Abbott Laboratories
|
106.31 | 182.59B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
92.69 | 118.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
272.54 | 106.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
45.82 | 65.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.56 | 49.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Eingeleitet | Wells Fargo | Overweight |
| 2025-12-01 | Eingeleitet | Mizuho | Outperform |
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Axogen Director Tyndall Joseph A. Disposes of 3,500 Shares at $49.70 Each - Kalkine Media
Axogen (AXGN) Director Joseph Tyndall Sells 3,500 Shares - GuruFocus
Axogen Inc (AXGN) Shares Fall 3.2% -- What GF Score of 64 Tells Investors - GuruFocus
Axogen (NASDAQ: AXGN) director plans $174K stock sale - Stock Titan
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference - Yahoo Finance
Axogen stock hits 52-week high at 51.13 USD By Investing.com - Investing.com South Africa
Axogen Inc (AXGN) Stock Up 3.3% but GF Value Says Overvalued -- GF Score: 64/100 - GuruFocus
Truist initiates AxoGen stock with buy rating on growth potential By Investing.com - Investing.com Canada
Truist Financial Initiates AxoGen(AXGN.US) With Buy Rating, Announces Target Price $60 - Moomoo
Axogen stock hits 52-week high at 51.13 USD - Investing.com
Axogen (AXGN) Close: Ends Lower by 2.32% at $49.23 in the Latest Reading; Immediate View - vinanet.vn
AxoGen (AXGN) Tops Q2 Earnings and Revenue Estimates - Eastern Progress
Axogen (AXGN) Price: Adds 8.53% to Close at $50.40 in the Latest Session; Market Levels: Price Remains Between $47.88 Support and $52.92 Resistance on the DayMedian Line - siam.in
Axogen Inc (AXGN) Shares Surge 8.5% -- What GF Score of 66 Tells Investors - GuruFocus
Axogen Inc (NASDAQ: AXGN) Share Price, AXGN Stock News, AXGN Share Price & Updates - kalkine.ca
Price to sales ratio of Axogen, Inc. – BMV:AXGN - TradingView
31,800 Shares in AxoGen, Inc. $AXGN Bought by Edmond DE Rothschild Holding S.A. - MarketBeat
Price to sales ratio of Axogen, Inc. – BIVA:AXGN - TradingView
Taxes of Axogen, Inc. – BMV:AXGN - TradingView
ETFs Investing in Axogen, Inc. Stocks - TradingView
AXGN Stock Price and Chart — BIVA:AXGN - TradingView
Cash per share of Axogen, Inc. – BMV:AXGN - TradingView
Axogen, Inc. Cash Flow – BIVA:AXGN - TradingView
Axogen, Inc. Statistics – BMV:AXGN - TradingView
Lisanti Capital Growth LLC Makes New Investment in AxoGen, Inc. $AXGN - MarketBeat
Tocqueville Asset Management L.P. Takes $8.03 Million Position in AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Sets New 52-Week HighHere's Why - MarketBeat
Axogen stock reaches 52-week high at 50.0 USD By Investing.com - Investing.com Canada
Axogen stock reaches 52-week high at 50.0 USD - Investing.com
Rice Hall James & Associates LLC Invests $3.41 Million in AxoGen, Inc. $AXGN - MarketBeat
689,833 Shares in AxoGen, Inc. $AXGN Bought by TimesSquare Capital Management LLC - MarketBeat
Axogen director Amy Wendell sells $646k in shares By Investing.com - Investing.com Australia
Axogen director Amy Wendell sells $646k in shares - Investing.com
First Light Asset Management (AXGN) discloses 7.58% Axogen stake for Mathew Arens - Stock Titan
Axogen (AXGN) Q2 2026 Earnings Call Transcript - AOL.com
Axogen EVP Marc Began Executes Stock Option Exercise and Sells Shares Under 10b5-1 Plan - Kalkine Media
Axogen Director Amy McBride-Wendell Executes and Sells 13,353 Shares Under 10b5-1 Plan - Kalkine Media
AxoGen (NASDAQ:AXGN) EVP Marc Began Sells 67,500 Shares of Stock - MarketBeat
AxoGen (NASDAQ:AXGN) Director Sells $646,552.26 in Stock - MarketBeat
Axogen Insider Sold Shares Worth $646,592, According to a Recent SEC Filing - marketscreener.com
Axogen Insider Sold Shares Worth $3,195,788, According to a Recent SEC Filing - marketscreener.com
Q4 2025 AxoGen Inc Earnings Call Transcript - GuruFocus
AxoGen, Inc. $AXGN Shares Sold by Wasatch Advisors LP - MarketBeat
Kathy Johnson Weiler Sells 14,150 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Axogen, Inc. SEC Filing (Aug 11, 2026) - Stock Titan
Axogen (AXGN) Is Up 5.4% After Raising 2026 Revenue Outlook Despite Ongoing Losses – Has The Bull Case Changed? - simplywall.st
Axogen Raises Its Revenue Outlook to at Least $279 Million But Does It Deserve An Upgrade? - Smartkarma
Axogen stock hits 52-week high at 47.09 USD By Investing.com - Investing.com South Africa
Axogen stock hits 52-week high at 47.09 USD - Investing.com India
AxoGen (NASDAQ:AXGN) Reaches New 52-Week HighTime to Buy? - MarketBeat
Axogen (AXGN) Climbs 3.86% to $48.22 as Medtech Momentum Builds Ahead of Key Resistance - dars.gov.et
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):